{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:32:35Z","timestamp":1770755555733,"version":"3.50.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,9]]},"DOI":"10.7759\/cureus.48557","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T12:31:48Z","timestamp":1699533108000},"source":"Crossref","is-referenced-by-count":3,"title":["Study of the Immunohistochemical Expression of p63 in Benign Lesions and Carcinoma of the Breast at a Tertiary Hospital in South India"],"prefix":"10.7759","author":[{"given":"Shreya Dinesh","family":"Prabhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan Sona","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakshatha","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramadas","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Jayasheelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0608-6","article-title":"Clinical relevance of the putative stem cell marker p63 in breast cancer","volume":"122","author":"Hanker L","year":"2010","unstructured":"Hanker L, Karn T, Ruckhaeberle E, et al.. Clinical relevance of the putative stem cell marker p63 in breast cancer. Breast Cancer Res Treat. 2010, 122:765-75. 10.1007\/s10549-009-0608-6","journal-title":"Breast Cancer Res Treat"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5858\/2003-127-0336-TRBPAP","article-title":"The relationship between p63 and p53 expression in normal and neoplastic breast tissue","volume":"127","author":"Ribeiro-Silva A","year":"2003","unstructured":"Ribeiro-Silva A, Zambelli Ramalho LN, Britto Garcia S, Zucoloto S. The relationship between p63 and p53 expression in normal and neoplastic breast tissue. Arch Pathol Lab Med. 2003, 127:336-40. 10.5858\/2003-127-0336-TRBPAP","journal-title":"Arch Pathol Lab Med"},{"key":"ref3","article-title":"Diagnostic evaluation of the papillary lesions of the breast","volume":"6","author":"Deepika H","year":"2021","unstructured":"Deepika H, Pritika N, Nikita C, Anita H. Diagnostic evaluation of the papillary lesions of the breast. Saudi J Pathol. 2021, 6:329-36.","journal-title":"Saudi J Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/107327481502200214","article-title":"Use of immunohistochemical stains in epithelial lesions of the breast","volume":"22","author":"Khazai L","year":"2015","unstructured":"Khazai L, Rosa M. Use of immunohistochemical stains in epithelial lesions of the breast. Cancer Control. 2015, 22:220-5. 10.1177\/107327481502200214","journal-title":"Cancer Control"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7860\/jcdr\/2021\/48358.15526","article-title":"Immunohistochemical expression of p63 in benign and malignant breast lesions","volume":"15","author":"Saini A","year":"2021","unstructured":"Saini A, Saluja AK, Garg MK, Agarwal D, Kulhria A, Sindhu A, Singh S. Immunohistochemical expression of p63 in benign and malignant breast lesions. J Clin of Diagn Res. 2021, 15: EC20-3. 10.7860\/jcdr\/2021\/48358.15526","journal-title":"J Clin of Diagn Res"},{"key":"ref6","article-title":"Diagnostic significance of immunohistochemistry in papillary breast neoplasms","volume":"40","author":"Bassyoni OY","year":"2023","unstructured":"Bassyoni OY, Elshawarby ZI, Abostate AM. Diagnostic significance of immunohistochemistry in papillary breast neoplasms. BMFJ. 2023, 40:516-27.","journal-title":"BMFJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9929.1000342","article-title":"Comparative immunohistochemical study of P63, SMA, CD10, and calponin in distinguishing in situ from invasive breast carcinoma","volume":"8","author":"Abdallah DM","year":"2017","unstructured":"Abdallah DM, El Deeb NMF. Comparative immunohistochemical study of P63, SMA, CD10, and calponin in distinguishing in situ from invasive breast carcinoma. J Mol Biomark Diagn. 2017, 8:4. 10.4172\/2155-9929.1000342","journal-title":"J Mol Biomark Diagn"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5772\/20337","article-title":"p53, p63 and p73 network in breast cancers","author":"Leong CO","year":"2011","unstructured":"Leong CO. p53, p63 and p73 network in breast cancers. Breast Cancer - Carcinogenesis, Cell Growth and Signalling Pathways. Gunduz M, Gunduz E (ed): Intechopen, London, UK; 2011. 10.5772\/20337"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.12.936","article-title":"p63 ataining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast","volume":"55","author":"Reis-Filho JS","year":"2002","unstructured":"Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC. p63 ataining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast. J Clin Pathol. 2002, 55:936-9. 10.1136\/jcp.55.12.936","journal-title":"J Clin Pathol"},{"key":"ref10","article-title":"Invasive ductal carcinoma with in situ pattern: how to avoid this diagnostic pitfall?","volume":"8","author":"Mohan N","year":"2016","unstructured":"Mohan N, Black JO, Schwartz MR, Zhai QJ. Invasive ductal carcinoma with in situ pattern: how to avoid this diagnostic pitfall?. Am J Transl Res. 2016, 8:3337-41.","journal-title":"Am J Transl Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14670\/HH-19.465","article-title":"p63 expression in benign and malignant breast lesions","volume":"19","author":"Stefanou D","year":"2004","unstructured":"Stefanou D, Batistatou A, Nonni A, Arkoumani E, Agnantis NJ. p63 expression in benign and malignant breast lesions. Histol Histopathol. 2004, 19:465-71. 10.14670\/HH-19.465","journal-title":"Histol Histopathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21276\/APALM.1954","article-title":"Role of p63 in breast carcinoma - a review","volume":"5","author":"Santara AK","year":"2018","unstructured":"Santara AK, Kumar A, Singh B, Doshetty R. Role of p63 in breast carcinoma - a review. APALM. 2018, 5:10.21276\/APALM.1954","journal-title":"APALM"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.12671.2","article-title":"Immunoexpression of P63 and SOX2 in triple-negative breast cancers, Indonesia","volume":"6","author":"Kamarlis RK","year":"2017","unstructured":"Kamarlis RK, Lubis MN, Hernowo BS, Kar AS. Immunoexpression of P63 and SOX2 in triple-negative breast cancers, Indonesia. F1000Res. 2017, 6:1780. 10.12688\/f1000research.12671.2","journal-title":"F1000Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11061","article-title":"Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples","volume":"99","author":"Reis-Filho JS","year":"2003","unstructured":"Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC. Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples. Cancer. 2003, 99:172-9. 10.1002\/cncr.11061","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20183255","article-title":"Role of p63 expression in non-proliferative and proliferative lesions breast lesions","volume":"6","author":"Verma N","year":"2018","unstructured":"Verma N, Sharma B, Singh P, Sharma SP, Rathi M, Raj D. Role of p63 expression in non-proliferative and proliferative lesions breast lesions. IJRMS. 2018, 6:2705-10. 10.18203\/2320-6012.ijrms20183255","journal-title":"IJRMS"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4161\/cc.6.3.3793","article-title":"The roles of p63 in cancer","volume":"6","author":"Flores ER","year":"2007","unstructured":"Flores ER. The roles of p63 in cancer. Cell Cycle. 2007, 6:300-4. 10.4161\/cc.6.3.3793","journal-title":"Cell Cycle"},{"key":"ref17","article-title":"Spectrum of papillary lesions of breast with immunohistochemistry and review of literature","volume":"4","author":"Bavikar R","year":"2017","unstructured":"Bavikar R, Deshmukh S, Khande T. Spectrum of papillary lesions of breast with immunohistochemistry and review of literature. Indian J Pathol Oncol. 2017, 4:52-5.","journal-title":"Indian J Pathol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.197","article-title":"Luminal cytokeratin expression profiles of breast papillomas and papillary carcinomas and the utility of a cytokeratin 5\/p63\/cytokeratin 8\/18 antibody cocktail in their distinction","volume":"24","author":"Reisenbichler ES","year":"2011","unstructured":"Reisenbichler ES, Balmer NN, Adams AL, Pfeifer JD, Hameed O. Luminal cytokeratin expression profiles of breast papillomas and papillary carcinomas and the utility of a cytokeratin 5\/p63\/cytokeratin 8\/18 antibody cocktail in their distinction. Mod Pathol. 2011, 24:185-93. 10.1038\/modpathol.2010.197","journal-title":"Mod Pathol"},{"key":"ref19","article-title":"Breast Tumours. WHO Classification of Tumours, 5th Edition, Volume 2","author":"WHO Classification of Tumours Editorial Board","year":"2019","unstructured":"WHO Classification of Tumours Editorial Board. Breast Tumours. WHO Classification of Tumours, 5th Edition, Volume 2. IARC Scientific Publications, Lyon, France; 2019."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/201553-study-of-the-immunohistochemical-expression-of-p63-in-benign-lesions-and-carcinoma-of-the-breast-at-a-tertiary-hospital-in-south-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:03Z","timestamp":1707509463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/201553-study-of-the-immunohistochemical-expression-of-p63-in-benign-lesions-and-carcinoma-of-the-breast-at-a-tertiary-hospital-in-south-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.48557","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,9]]}}}